Media

Savonix brings you the world’s first clinical, evidence-based, and all-mobile digital assessment of cognitive and emotional function. For micro-testing at frequent intervals, the test takes as little as three minutes. For a fully integrated neuropsychological battery of 12 domains, testing requires up to 30 minutes. Savonix works with any iOS or Android device and is available via license with healthcare organizations and other third-party partners.

It is estimated that nearly 500,000 new cases of Alzheimer's disease will be diagnosed this year in the United States. Every 3 seconds, someone in the world develops dementia.

Memory impairment is not always the first symptom of dementia disorders. Studies show that up to 20 percent of people who later develop dementia show no signs of memory impairment in the early stages and that impairments in one domain alone are often benign.
In contrast, studies have also shown that multidomain assessment can pick up a range of cognitive problems at an early stage and up to 60 percent of people who later develop dementia present with multidomain impairments at the mild cognitive impairment (MCI) stage.